NCT05657873 2026-03-27
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
Clinical Trials
11 trialsNCT03808337 2026-02-27
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT04602533 2026-02-27
Efficacy and Safety of Standard of Care Plus Durvalumab in Patients With Limited Disease Small Cell Lung Cancer (DOLPHIN)
Johannes Gutenberg University Mainz
Phase 2 Active not recruiting
NCT07250477 2026-02-09
Risk-adapted, Proteomic-guided Systemic Therapy for Previously Untreated Advanced Non-small Cell Lung Cancer
University of California, Davis
Phase 2 Recruiting
NCT03808662 2026-02-04
Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT04067830 2025-09-05
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Roswell Park Cancer Institute
Phase 2 Recruiting
NCT03217071 2024-10-23
Pembrolizumab With and Without Radiotherapy for Non-Small Cell Lung Cancer
University of California, San Francisco
Phase 2 Completed
NCT04405401 2023-12-12
SUPPRESS-NSCLC
Centre hospitalier de l'Université de Montréal (CHUM)
Phase 2 Recruiting
NCT03628144 2020-09-10
Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Withdrawn
NCT03472053 2020-05-19
A Study of BIO-11006 in the Treatment of Advanced Non-Small Cell Lung Cancer
BioMarck Pharmaceuticals, Ltd.
Phase 2 Completed
NCT02200081 2018-11-15
IMPULSE
Mologen AG
Phase 2 Completed